Given the apparent outcome it seems you are correct and we are stuck with 'snail-mail' progress while potentially competitive therapies (that are possibly standalone) are no doubt being developed... including the use of stem cells and perhaps even 3D printing of pancreas and/or stomach.
Regarding further CR this might be of interest - Gastrointestinal average cost Phase 2 trial USD $15.8M
https://www.centerpointclinicalserv...-access-part-1-clinical-trial-cost-breakdown/
so perhaps another $7-10m will do it!
Cheers
Ann: Trading Halt, page-76
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $424.5M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $1.032M | 18.08M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 90000 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 744737 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.8¢ |
Change
0.000 ( 1.03 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.6¢ | 4924782 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| IMU (ASX) Chart |